SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

International Business Machines Corp. is an information technology company, which engages in the provision of integrated solutions that leverage information technology and knowledge of business processes. It operates through the following segments: Software, Consulting, Infrastructure, Financing, and Other. The Software segment combines hybrid cloud platform and software solutions to help clients become more data-driven, and to automate, secure, and modernize their environments. The Consulting segment focuses on integrating skills on strategy, experience, technology and operations by domain and industry. The Infrastructure segment offers solutions for hybrid cloud and is the foundation of the hybrid cloud stack. Infrastructure is optimized for infusing AI into mission-critical transactions and tightly integrated with IBM Software including Red Hat for accelerated hybrid cloud benefits. The Financing segment refers to the client and commercial financing, facilitating IBM clients’ acquisition of IT systems, software, and services. The company was founded by Charles Ranlett Flint and Thomas J. Watson Sr. on June 16, 1911 and is headquartered in Armonk, NY.

International Business Machines Corp.

IBM is trending sharply lower following Anthropic's announcement of AI tools capable of automating COBOL modernization, triggering widespread market debate and concern over AI's disruptive potential for IBM's legacy consulting and mainframe services. Many in the community, however, view the steep sell-off as an overreaction, citing IBM's existing partnership with Anthropic and its strong fundamentals in hybrid cloud and quantum computing.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is trending as its latest earnings, featuring an EPS beat and raised full-year guidance, ignite debate among investors; bulls foresee a short squeeze driven by solid growth and high short interest, while bears focus on a revenue miss and regulatory headwinds surrounding its compounded GLP-1 offerings.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending as the tech-heavy market navigates fresh anxieties surrounding AI's disruptive impact on software and white-collar jobs, alongside renewed global tariff uncertainties and geopolitical tensions, prompting community debate over its surprising resilience against bearish catalysts.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is trending amid intense community debate following a Supreme Court ruling on past tariffs and subsequent new tariff announcements, with many discussing potential economic impacts and legal challenges to Trump's policies. The stock's volatile performance and its strong link to ongoing political controversies, including renewed scrutiny of its namesake's past associations, continue to fuel highly polarized sentiment among investors.

Warner Bros. Discovery, Inc. is a premier global media and entertainment company, which engages in the provision of a differentiated portfolio of content, brands, and franchises across television, film, streaming, and gaming. It operates through the following segments: Studios, Networks, Direct-to-Consumer (DTC), and Corporate. The Studios segment includes producing and releasing feature films for initial exhibition in theaters, producing and initial licensing television programs to networks services as well as third parties, distributing films and television programs to various third party, internal television, and streaming services, distribution through the home entertainment market related consumer products, and themed experience licensing and interactive gaming. The Networks segment focuses on domestic and international television networks. The DTC segment is involved in premium pay-television and streaming services. The company was founded on June 17, 1985 and is headquartered in New York, NY.

Warner Bros. Discovery Inc - Ordinary Shares - Class A

Warner Bros Discovery Inc

Warner Bros Discovery is trending as Paramount Skydance's recently "sweetened" acquisition offer has prompted WBD to reopen talks, fueling community debate over the best path to shareholder value amidst ongoing regulatory scrutiny of Netflix's competing bid.

CrowdStrike Holdings, Inc. provides cybersecurity products and services to stop breaches. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, Zero Trust identity protection, and log management. CrowdStrike serves customers worldwide. The company was founded by George P. Kurtz, Gregg Marston, and Dmitri Alperovitch on November 7, 2011 and is headquartered in Austin, TX.

Crowdstrike Holdings Inc - Ordinary Shares - Class A

Crowdstrike Holdings Inc

Crowdstrike is trending as concerns rise after Anthropic introduced its Claude Code Security tool, sparking a sector-wide selloff amid fears that AI could disrupt established cybersecurity business models, while many in the community argue it's an overreaction and a buying opportunity for the company's core offerings.

JPMorgan Chase & Co. is a financial holding company, which engages in the provision of financial and investment banking services. It focuses on investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. It operates through the following segments: Consumer and Community Banking (CCB), Commercial and Investment Bank (CIB), Asset and Wealth Management (AWM), and Corporate. The CCB segment originates and services mortgage loans. The CIB segment makes markets and services clients across fixed income, foreign exchange, equities, and commodities. The AWM segment provides initial capital investments in products such as mutual funds and capital invested alongside third-party investors. The Corporate segment manages its liquidity, funding, capital, structural interest rate, and foreign exchange risks. The company was founded in 1799 and is headquartered in New York, NY.

JPMorgan Chase & Co.

JPMorgan Chase & Co

JPMorgan Chase is a key topic as former President Trump's $5 billion lawsuit alleging political debanking fuels widespread discussion, while community perspectives also highlight the bank's past Epstein controversies. This trending conversation contrasts with the bank's robust net interest income outlook and strategic expansion plans, alongside its increasingly bullish view on crypto assets.

Atlassian Corp. is a holding company, which engages in providing team collaboration and productivity software. Its products include Jira Software, Confluence, Jira Service Management, and Loom. The company was founded by Michael Cannon-Brookes and Scott Farquhar in October 2002 and is headquartered in San Francisco, CA.

Atlassian Corporation - Ordinary Shares - Class A

Atlassian Corporation Plc

Atlassian ($TEAM) is trending amid a dramatic stock decline, even after reporting solid financials, as investor panic over the "AI disruption" narrative weighs heavily on the broader SaaS sector; community discussion is sharply divided between fears of impending bankruptcy and strong conviction that the stock is "criminally oversold."

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending due to the escalating bidding war for Warner Bros. Discovery, with the community intensely debating whether the company should match Paramount's higher offer or walk away, especially given widening DOJ antitrust scrutiny and political pressure impacting the deal.

Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The firm's technology platforms include antibody, T cell, innate immunity and siRNA, which are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. The company was founded by Robert Taylor Nelsen, Klaus Frueh, Jay Parrish, Lawrence Corey, and Louis Picker in April 7, 2016 and is headquartered in San Francisco, CA.

Vir Biotechnology Inc

Vir Biotechnology is trending due to a global strategic collaboration with Astellas for its prostate cancer T-cell engager, VIR-5500, backed by promising updated Phase 1 data. The community is actively discussing the potential for a significant run, with some anticipating a short squeeze, while others remain cautious, expecting a historical pullback.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shares of pharma giant Eli Lilly &amp; Co (LLY) jumped over 13% on Thursday after the company surpassed Wall Street’s second-quarter estimates and raised its full-year guidance.The firm reported earnings per share (EPS) of $3.92 compared to an estimate of $2.60 while revenue came in at $11.30 billion versus an estimate of $9.92 billion.However, the highlight of the earnings report came in the form of an increase in its full-year guidance by $3 billion to the range of $45.40 billion to $46.60 billion. Management’s upgraded outlook was primarily driven by the strong performance of Mounjaro and Zepbound, as well as the firm’s non-incretin medicines.Eli Lilly also increased its EPS guidance to the range of $15.10 to $15.60 on a reported basis compared to a previous guidance of $13.05 to $13.55. Non-GAAP EPS is expected to come in at $16.10-16.60 compared to prior guidance of $13.50-14.00.Following the upbeat announcement, retail sentiment on Eli Lilly continued to trend in the ‘bullish’ territory (65/100) amid ‘high’ message volumes.<figure class="image"><a href="https://stocktwits.com/symbol/LLY"><img style="aspect-ratio:1882/522;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_08_08_at_9_19_54_AM_bfa85cd852.png" alt="Eli Lilly sentiment meter as of 8:48 a.m. EST on August 08, 2024" width="1882" height="522"></a><figcaption>Eli Lilly sentiment meter as of 8:48 a.m. EST on August 08, 2024</figcaption></figure>David A. Ricks, Lilly's chair and CEO said Mounjaro, Zepbound and Verzenio led the firm’s strong financial performance during the quarter. "We also recently received approval of Kisunla to help people with Alzheimer's disease, a moment that was decades in the making,” he said.During the second quarter, worldwide Mounjaro revenue stood at $3.09 billion versus $979.70 million in Q2 2023. Mounjaro is an injectable medicine for type-2 diabetes in adults. Zepbound, which launched in the U.S. for the treatment of adult patients with obesity or overweight with weight-related co-morbidities, saw U.S. revenue come in at $1.24 billion.The firm’s pipeline progress included approval of Kisunla in the U.S. for Alzheimer's disease and Jaypirca in Japan for relapsed or refractory mantle cell lymphoma.Some Stocktwits users, including "HighBetaAlgorithms" are bullish on the stock given that obesity has been a widespread problem in the U.S. and a growing concern globally.<stembedurl>https://stocktwits.com/HighBetaAlgorithms/message/582263226</stembedurl>

Eli Lilly reported earnings per share of $3.92 compared to an estimate of $2.60

Eli Lilly Raises Full-Year Guidance By Whopping $3 Billion, Draws Retail Cheer

The major highlight of the pharmaceutical giant’s earnings came in the form of an increase in its full-year guidance by $3 billion to the range of $45.40 billion to $46.60 billion. 

Eli Lilly Raises Full-Year Guidance By Whopping $3 Billion

Equity

The major highlight of the pharmaceutical giant’s earnings came in the form of an increase in its full-year guidance by $3 billion to the range of $45.40 billion to $46.60 billion. The upgraded outlook was primarily driven by the strong performance of Mounjaro and Zepbound, as well as the firm’s non-incretin medicines.

CURE
Direxion Daily Healthcare Bull 3X Shares

Feed

News

Sentiment

Fundamentals

Info

Latest CURE News

CUREDirexion Daily Healthcare Bull 3X Shares